BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES is a prestigious journal dedicated to advancing the field of biomembrane research, published by Elsevier. With a notable track record since its inception in 1967, this journal operates under the dual ISSN 0005-2736 and E-ISSN 1879-2642, and has firmly established itself within the scientific community by ranking in the top tiers of various disciplines, including Q2 in Biochemistry and Cell Biology, and Q1 in Biophysics as of 2023. Its impressive Scopus rankings further underscore its importance, with a rank of 24 in Biophysics reflecting its strong impact on ongoing research. Although it does not offer open access, the journal provides comprehensive insights and breakthroughs essential for scientists, researchers, and advanced students focused on biophysical and biochemical aspects of membranes. By disseminating pivotal findings, BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES contributes significantly to understanding cellular mechanisms, thereby serving as a vital resource for professionals aiming to explore the complexities of biological membranes.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

PHYCOLOGICAL RESEARCH is a leading journal in the field of aquatic and plant sciences, published by Wiley, recognized for its commitment to advancing knowledge in the study of algae and their ecological significance. With a diverse scope encompassing ecological interactions, evolutionary behaviors, and physiological processes, PHYCOLOGICAL RESEARCH aims to provide a platform for researchers to disseminate innovative findings and insights pertinent to both agricultural and biological sciences. The journal's impressive rankings—placing it in the 74th percentile within Agricultural and Biological Sciences (miscellaneous) and holding a Q2 category in key fields—underscore its impact and importance in academia. Despite not being open access, the journal ensures broad distribution and visibility through its dedicated readership. Since its inception in 1995, PHYCOLOGICAL RESEARCH has continuously evolved, shaping and influencing the direction of research in phycology and related disciplines, making it an essential resource for students, professionals, and researchers alike.

Cancer & Metabolism is a distinguished open-access journal published by BMC, dedicated to advancing the understanding of the complex interactions between cancer biology and metabolic processes. Since its inception in 2013, it has provided a platform for researchers, clinicians, and students to disseminate groundbreaking research and innovative findings within the fields of oncology and metabolism. The journal, identified by its E-ISSN 2049-3002, is recognized for contributing valuable insights into metabolic alterations that influence cancer progression, treatment responses, and overall patient outcomes. With a firm commitment to open access, Cancer & Metabolism ensures that research is freely available to the global scientific community, fostering collaboration and accelerating discoveries that can lead to improved therapeutic strategies. As a vital resource in cancer research, this journal appeals to a broad audience, including researchers looking to share their latest findings, professionals seeking to stay informed on cutting-edge developments, and students eager to delve into the relationship between metabolism and cancer.

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

Chemistry and Physics of Lipids is a prestigious and influential journal dedicated to advancing the understanding of lipid chemistry and biophysics. Published by Elsevier Ireland Ltd, it serves as a vital resource for researchers and professionals in the fields of biochemistry, cell biology, and molecular biology. The journal has a strong standing within the academic community, as reflected in its 2023 Scopus rankings, where it places in the 82nd percentile for organic chemistry and maintains significant positions in various biochemistry subfields. Spanning from 1966 to 2024, it fosters a comprehensive discourse on lipid-related research and innovation. As a renowned publication in the Q2 and Q3 quartiles across several categories, it supports the dissemination of high-quality research aimed at elucidating lipid functions and their implications in health and disease. Researchers and students alike will find this journal invaluable for staying updated with the latest developments and trends in lipid research.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

PPAR Research, an esteemed journal published by HINDAWI LTD, specializes in the rapidly evolving fields of drug discovery and pharmacology, contributing significantly to the body of research surrounding peroxisome proliferator-activated receptors (PPARs) and their roles in various biochemical processes. With an open access policy implemented since 2006, the journal ensures that its high-quality content is readily available, promoting widespread dissemination of knowledge. Currently ranked in the Q2 category for both Drug Discovery and Medical Pharmacology, it boasts a respectable position within the scientific community, evidenced by its Scopus rankings. PPAR Research serves as an essential resource for researchers, professionals, and students looking to advance their understanding of PPAR biology and its implications in therapeutic development. The journal's commitment to excellence and accessibility makes it a key player in supporting innovative research and critical discussions in the life sciences.

Journal of Endocrinology and Metabolism is a dynamic and essential publication in the field of endocrinology, diabetes, and metabolism, published by ELMER PRESS INC in Canada. With an ISSN of 1923-2861 and E-ISSN 1923-287X, this journal serves as a pivotal platform for sharing innovative research and advancements from 2018 through 2024. Although categorized in the fourth quartile (Q4) for 2023, its commitment to high-quality research is reflected in its ongoing efforts to foster scholarly dialogue and illuminate critical issues within its scope. Targeting primarily researchers, healthcare professionals, and students, the journal aims to disseminate crucial findings that advance our understanding of endocrine functions and metabolic processes. Given its Scopus ranking of #207 out of 244 within its category, the Journal of Endocrinology and Metabolism continues to contribute to the global discourse on these vital health topics.